Ion Peptides

Latest sync: Jul 13, 2026, 7:18 AM. Source coverage currently reflects Peptide Critic data.

Curated
Transparency type
Public document layer
Access pattern
Publicly inspectable
Best for

Readers who want a vendor that at least surfaces lab-results access and testing methodology publicly instead of hiding all quality information behind support channels.

Watch-out

Ion’s public posture is promising, but the trust read is still incomplete until we inspect the actual COA / lab-results routes more systematically.

Included because it now has a clearer U.S. footprint, visible COA navigation, and a public quality-assurance layer that is stronger than a bare storefront.

Ion publicly surfaces COA navigation, “View Lab Test Results,” QR-and-batch-verified positioning, and a more developed quality-assurance explanation than many smaller peptide sites.

Testing transparency
Vendor-hosted public documents
Public Docs
Publicly inspectable
Public COA navigation and lab-results entry point

Ion publicly exposes a `COA` navigation path and a `View Lab Test Results` entry point, while also describing QR-and-batch-verified COA documentation, HPLC, and mass spectrometry in its quality-assurance copy. That is enough to justify curated inclusion, but a deeper review is still needed to determine whether the lab-results layer is broadly public, thin, or partly performative.

This vendor is one of 50 names currently included in our manual curated research-vendor layer.

View curated vendor page View transparency view View compare page

This is a meaningful public transparency pattern, but the documents are still mostly hosted on the vendor side. That makes it stronger than generic claims and weaker than provider-controlled verification.

  • Reward the fact that readers can inspect real files without logging in.
  • Pay attention to whether the archive is broad, multi-category, or repeated across many products.
  • Keep in mind that vendor-hosted files are different from a live third-party verification portal.
Read transparency methodology Browse similar transparency patterns

This vendor makes the most sense when you compare it to other vendors using a similar transparency model, rather than to every vendor on the board at once.

Open vendor compare Open vendor/provider bridge

PB Curated Assessment is a PeptideBenchmark-authored rubric built from the trust and transparency review layer. It is separate from the source-derived benchmark score.

Mixed curated case

Ion Peptides has some real trust signal, but the current evidence footprint is still mixed, narrow, or partially gated.

Evidence access
Open public documents
Verification structure
Structured public archive
Evidence depth
Unclear
Lab context
Little named-lab context
Evidence access
Open public documents

Readers can inspect real public documents, even if the vendor still hosts most of the archive.

Verification structure
Structured public archive

The trust layer is structured and inspectable, but still mostly vendor-controlled.

Evidence depth
Unclear

Current review has not yet established broad product-level evidence depth.

Lab context
Little named-lab context

The current evidence layer is still thin on clearly named outside-lab context.

How to read this benchmark

This profile summarizes public benchmark data synced from Finnrick and, when available, Peptide Critic. Finnrick contributes a 10-point average from its vendor table, while Peptide Critic contributes a 5-star rating that we normalize to a 10-point scale before ranking consensus entries.

A high score can be directionally useful, but it is not a substitute for current COAs, identity testing, chain-of-custody details, or your own due diligence. We are intentionally separating source aggregation from first-party editorial claims.

Scores combine PB trust evidence with external signals from Finnrick, Peptide Critic, Trustpilot, and Pep Review Pro when available.